Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HVPG-guided therapy vs Carvedilol + EBL for esophageal variceal rebleeding
NCT04254822Unknown
- Sponsor
- Air Force Medical University
- Start
- Jun 2020
- Primary completion
- Dec 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of carvedilol in Esophageal variceal hemorrhage (EVH) (2 arms), sponsored by Air Force Medical University. Primary endpoint: Cumulative incidence of esophageal variceal rebleeding at 12 months. Status: unknown.
02
Drugs
carvedilol
03
Conditions
Esophageal variceal hemorrhage (EVH)
Beyond the preview
Go deeper on NCT04254822.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04254822.